Technology Solutions

Certara launches e-learning platform for biosimulation education

Thursday, April 28, 2016

Certara, a global biosimulation technology-enabled drug development company, has launched an e-learning platform through Certara University to satisfy the increased need for education in the burgeoning field of biosimulation or model-based drug development. With the addition of this new on-demand content, scientists from all over the world, with differing skill levels in biosimulation, will be able to access the educational assets developed by Certara’s scientific leaders. 

[Read More]

MSOAC launches database for MS clinical trial data

Tuesday, April 26, 2016

A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators. This is just one of the tools generated through the Multiple Sclerosis Outcome Assessments Consortium (MSOAC), a global effort launched by the National MS Society and Critical Path Institute (C-Path). MSOAC is striving to develop an outcomes measure that addresses the critical need for a more sensitive way to detect the benefit of potential treatments that slow or reverse progressive disability in people with MS.

[Read More]

BePATIENT, Vital Connect launch BeVITAL

Tuesday, April 26, 2016

Vital Connect, a provider of design and deployment of wearable biosensor technologies, and BePATIENT, a startup that develops patient-centric digital health solutions, has announced the first North American deployment of BeVITAL. The remote patient monitoring solution combines VitalConnect’s FDA-cleared biosensor, HealthPatch MD, with BePATIENT’s web-based solution and associated app, which allows the implementation of personalized healthcare programs accessible through mobile devices and computers.

[Read More]

Bracket launches patient engagement tools for eCOA, RTSM

Monday, April 25, 2016

Bracket, a clinical trial specialty services provider, has announced platform updates to Bracket eCOA and Bracket RTSM to include native support for SMS messaging with patients and other stakeholders in clinical research programs. This important update expands the medication compliance and adherence functionality across Bracket’s eClinical portfolio, and provides an effective solution for supporting patients participating in clinical trials.

[Read More]

DNAnexus, Solvebio partner to make genomic data more actionable

Thursday, April 21, 2016

DNAnexus, a cloud-based genome informatics and data management provider, has announced a partnership with SolveBio, a global provider of Genomics Intelligence, to integrate the two platforms and provide seamless access to SolveBio’s curated data and analysis services. Researchers globally will have the ability to move quickly from genomic data analysis to interpretation, freeing up time to focus on generating uniquely actionable biological insights.

[Read More]

Medrio, Clinartis partner

Thursday, April 21, 2016

Medrio, a Software as a Service (SaaS) company providing cloud-based data management capabilities to clinical researchers, and Clinartis, a CRO providing clinical trial services in the U.S. and Europe, have announced a new partnership under Medrio’s Partner Program. Clinartis and Medrio have cultivated a business relationship through numerous phase I studies for which the CRO has utilized Medrio’s flagship phase I-focused product, m1.

[Read More]

Finding investigators and patients for faster trials

Friday, April 15, 2016

In the January issue of The CenterWatch Monthly, I wrote about using insurance claims and electronic health records (EHR) to understand patient availability for clinical trials. Combined, these sources can tell you if enough patients meet the criteria, enabling redesign and better planning.

[Read More]

Certara launches SIVA Toolkit 2.0 for in vitro analysis

Wednesday, April 13, 2016

Certara, a global biosimulation technology-enabled drug development company, has launched the Simcyp In Vitro (Data) Analysis (SIVA) Toolkit 2.0 to assist drug development researchers with the analysis of complex in vitro studies. These studies are used to assess candidate drugs’ metabolism, transport and formulation properties.

[Read More]